Aldeyra Therapeutics, Inc. - Common Stock (ALDX)
CUSIP: 01438T106
Q3 2017 13F Holders as of 30 Sep 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 59,794,743
- Total 13F shares
- 9,221,517
- Share change
- +1,806,662
- Total reported value
- $66,394,000
- Price per share
- $7.20
- Number of holders
- 35
- Value change
- +$13,267,111
- Number of buys
- 28
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 01438T106?
CUSIP 01438T106 identifies ALDX - Aldeyra Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 01438T106:
Top shareholders of ALDX - Aldeyra Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
4.8%
|
2,885,458
|
$13,417,000 | — | 30 Jun 2017 | |
| FMR LLC |
13F
|
Company |
2.8%
|
1,654,311
|
$7,775,000 | — | 30 Jun 2017 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1.5%
|
875,931
|
$4,117,000 | — | 30 Jun 2017 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.88%
|
525,093
|
$2,442,000 | — | 30 Jun 2017 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.79%
|
475,000
|
$2,209,000 | — | 30 Jun 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.51%
|
304,633
|
$1,431,000 | — | 30 Jun 2017 | |
| Knoll Capital Management, LLC |
13F
|
Company |
0.21%
|
124,096
|
$583,000 | — | 30 Jun 2017 | |
| Hikari Power Ltd |
13F
|
Company |
0.18%
|
107,858
|
$507,000 | — | 30 Jun 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.17%
|
100,500
|
$467,000 | — | 30 Jun 2017 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
97,704
|
$454,000 | — | 30 Jun 2017 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.1%
|
62,000
|
$288,000 | — | 30 Jun 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
57,854
|
$271,000 | — | 30 Jun 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.09%
|
55,300
|
$257,000 | — | 30 Jun 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.07%
|
39,544
|
$184,000 | — | 30 Jun 2017 | |
| Virtu KCG Holdings LLC |
13F
|
Company |
0.04%
|
22,431
|
$104,000 | — | 30 Jun 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
14,999
|
$70,000 | — | 30 Jun 2017 | |
| ARDSLEY ADVISORY PARTNERS LP |
13F
|
Company |
0.02%
|
14,552
|
$68,000 | — | 30 Jun 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
9,000
|
$42,000 | — | 30 Jun 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2,793
|
$13,000 | — | 30 Jun 2017 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
2,451
|
$11,000 | — | 30 Jun 2017 | |
| NEXT Financial Group, Inc |
13F
|
Company |
0%
|
2,000
|
$9,000 | — | 30 Jun 2017 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0%
|
1,800
|
$8,000 | — | 30 Jun 2017 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,108
|
$5,000 | — | 30 Jun 2017 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0%
|
870
|
$4,000 | — | 30 Jun 2017 |
Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock (ALDX) as of Q3 2017
As of 30 Sep 2017,
Aldeyra Therapeutics, Inc. - Common Stock (ALDX) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,221,517 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, FMR LLC, SPHERA FUNDS MANAGEMENT LTD., 683 Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, Knoll Capital Management, LP, Hikari Power Ltd, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2017 vs Q2 2017 Across Filers
Q2 2017 holders
24
Q3 2017 holders
35
Holder diff
11
| Investor | Q2 2017 Shares | Q3 2017 Shares | Share Diff | Share Chg % | Q2 2017 Value $ | Q3 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.